Literature DB >> 28915522

Comparison of Platelet-Rich Plasma, Stromal Vascular Fraction (SVF), or SVF with an Injectable PLGA Nanofiber Scaffold for the Treatment of Osteochondral Injury in Dogs.

Samuel P Franklin1,2, Aaron M Stoker3, Chantelle C Bozynski4, Keiichi Kuroki4, Kevin M Clarke1, Jed K Johnson5, James L Cook3.   

Abstract

Stromal vascular fraction (SVF) contains a small number of mesenchymal stem cells and has been used as a treatment for osteoarthritis and cartilage injury. Due to limited evidence of successful cartilage regeneration with injected stem cell therapies, there is interest in combining cellular therapies with injectable scaffolding materials to increase intra-articular residence times of stem cells and improve tissue regeneration. However, the safety of intra-articular injection of SVF combined with injectable scaffolds is unestablished. Also, it is unclear if SVF therapy is superior to more easily prepared biologics, such as platelet-rich plasma (PRP). The purpose of this study was to assess the safety of SVF when combined with an injectable poly(L-lactide-co-glycolide) nanofiber scaffold and to provide a comparison of SVF therapy to PRP. A total of 12 Beagles had osteochondral defects created in both medial femoral condyles and 4 dogs each were allocated to treatment groups of SVF (n = 4), SVF plus PLGA scaffolding (n = 4), or leukoreduced PRP (n = 4). One knee in each dog received treatment, and the contralateral knee was sham treated with saline. Dogs were assessed over a 6-month period, and outcome measures included functional, radiographic, biochemical, and histological assessments. PRP treatment resulted in improvements in lameness scores and objective kinetic assessments of function. There were no statistically significant improvements in function, cartilage biochemical composition, or histology for SVF-treated knees. The combination of SVF and the injectable PLGA scaffold had worse outcomes than other groups including sham treatment based upon functional, biochemical, and histological assessments, raising concerns over the safety of this scaffold for intra-articular injection. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28915522     DOI: 10.1055/s-0037-1606575

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  4 in total

Review 1.  Intra-articular injection of stromal vascular fraction for knee degenerative joint disease: a concise review of preclinical and clinical evidence.

Authors:  Yuan Liu; Liping Huang; Yi Zeng; Mingyang Li; Huiqi Xie; Bin Shen
Journal:  Sci China Life Sci       Date:  2022-05-05       Impact factor: 10.372

2.  Pooled Platelet-Rich Plasma Lysate Therapy Increases Synoviocyte Proliferation and Hyaluronic Acid Production While Protecting Chondrocytes From Synoviocyte-Derived Inflammatory Mediators.

Authors:  Jessica M Gilbertie; Julie M Long; Alicia G Schubert; Alix K Berglund; Thomas P Schaer; Lauren V Schnabel
Journal:  Front Vet Sci       Date:  2018-07-04

3.  Assessment of Canine Autologous Conditioned PlasmaTM Cellular and Transforming Growth Factor-β1 Content.

Authors:  Samuel P Franklin; Kate E Birdwhistell
Journal:  Front Vet Sci       Date:  2018-06-11

4.  Clinical applications of adipose-derived stromal vascular fraction in veterinary practice.

Authors:  Khan Sharun; Kaveri Jambagi; Rohit Kumar; Mudasir Bashir Gugjoo; Abhijit M Pawde; Hardeep Singh Tuli; Kuldeep Dhama
Journal:  Vet Q       Date:  2022-12       Impact factor: 8.071

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.